Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
Loriot, Y., Bianchini, D., Ileana, E., Sandhu, S., Patrikidou, A., Pezaro, C., Albiges, L., Attard, G., Fizazi, K., De Bono, J.S., Massard, C.
Published in Annals of oncology (01.07.2013)
Published in Annals of oncology (01.07.2013)
Get full text
Journal Article
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
Bianchini, D, Lorente, D, Rodriguez-Vida, A, Omlin, A, Pezaro, C, Ferraldeschi, R, Zivi, A, Attard, G, Chowdhury, S, de Bono, J.S
Published in European journal of cancer (1990) (01.01.2014)
Published in European journal of cancer (1990) (01.01.2014)
Get full text
Journal Article
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?
Mezynski, J., Pezaro, C., Bianchini, D., Zivi, A., Sandhu, S., Thompson, E., Hunt, J., Sheridan, E., Baikady, B., Sarvadikar, A., Maier, G., Reid, A.H.M., Mulick Cassidy, A., Olmos, D., Attard, G., de Bono, J.
Published in Annals of oncology (01.11.2012)
Published in Annals of oncology (01.11.2012)
Get full text
Journal Article
Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer
OMLIN, A, PEZARO, C. J, VAN AS, N, DE BONO, J. S, ATTARD, G, ZAIDI, S, LORENTE, D, MUKHERJI, D, BIANCHINI, D, FERRALDESCHI, R, SANDHU, S, DEARNALEY, D, PARKER, C
Published in British journal of cancer (03.09.2013)
Published in British journal of cancer (03.09.2013)
Get full text
Journal Article
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial
Annala, M., Fu, S., Bacon, J.V.W., Sipola, J., Iqbal, N., Ferrario, C., Ong, M., Wadhwa, D., Hotte, S.J., Lo, G., Tran, B., Wood, L.A., Gingerich, J.R., North, S.A., Pezaro, C.J., Ruether, J.D., Sridhar, S.S., Kallio, H.M.L., Khalaf, D.J., Wong, A., Beja, K., Schönlau, E., Taavitsainen, S., Nykter, M., Vandekerkhove, G., Azad, A.A., Wyatt, A.W., Chi, K.N.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
Visceral Disease in Castration-resistant Prostate Cancer
Pezaro, Carmel J, Omlin, Aurelius, Lorente, David, Nava Rodrigues, Daniel, Ferraldeschi, Roberta, Bianchini, Diletta, Mukherji, Deborah, Riisnaes, Ruth, Altavilla, Amelia, Crespo, Mateus, Tunariu, Nina, de Bono, Johann S, Attard, Gerhardt
Published in European urology (01.02.2014)
Published in European urology (01.02.2014)
Get full text
Journal Article
Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone
LORENTE, D, OMLIN, A, DEARNALEY, D, GILLESSEN, S, DE BONO, J, ATTARD, G, FERRALDESCHI, R, PEZARO, C, PEREZ, R, MATEO, J, ALTAVILLA, A, ZAFEIROU, Z, TUNARIU, N, PARKER, C
Published in British journal of cancer (09.12.2014)
Published in British journal of cancer (09.12.2014)
Get full text
Journal Article
Abiraterone and novel antiandrogens: overcoming castration resistance in prostate cancer
Ferraldeschi, R, Pezaro, C, Karavasilis, V, de Bono, J
Published in Annual review of medicine (01.01.2013)
Published in Annual review of medicine (01.01.2013)
Get more information
Journal Article
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Leibowitz-Amit, R., Templeton, A.J., Omlin, A., Pezaro, C., Atenafu, E.G., Keizman, D., Vera-Badillo, F., Seah, J.-A., Attard, G., Knox, J.J., Sridhar, S.S., Tannock, I.F., de Bono, J.S., Joshua, A.M.
Published in Annals of oncology (01.03.2014)
Published in Annals of oncology (01.03.2014)
Get full text
Journal Article
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer
BIANCHINI, D, OMLIN, A, ZIVI, A, BUCHBINDER, A, RATHKOPF, D. E, ATTARD, G, SCHER, H. I, DE BONO, J, DANILA, D. C, PEZARO, C, LORENTE, D, FERRALDESCHI, R, MUKHERJI, D, CRESPO, M, FIGUEIREDO, I, MIRANDA, S, RIISNAES, R
Published in British journal of cancer (12.11.2013)
Published in British journal of cancer (12.11.2013)
Get full text
Journal Article
Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone
Massard, C., Mateo, J., Loriot, Y., Pezaro, C., Albiges, L., Mehra, N., Varga, A., Bianchini, D., Ryan, C.J., Petrylak, D.P., Attard, G., Shen, L., Fizazi, K., de Bono, J.
Published in Annals of oncology (01.01.2017)
Published in Annals of oncology (01.01.2017)
Get full text
Journal Article
Examining skeletal-related events in Australian men with castration-resistant prostate cancer (CRPC)
Anton, A., Wong, S., Parente, P., Azad, A., Shapiro, J.A., Weickhardt, A., Torres, J., Parnis, F., Goh, J., Semira, C., Gibbs, P., Tran, B., Pezaro, C.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer
PEZARO, C, MUKHERJI, D, ATTARD, G, TUNARIU, N, CASSIDY, A. M, OMLIN, A, BIANCHINI, D, SEED, G, REID, A. H. M, OLMOS, D, DE BONO, J. S
Published in British journal of cancer (23.07.2013)
Published in British journal of cancer (23.07.2013)
Get full text
Journal Article
A randomized phase II study of cabazitaxel (CAB) vs (ABI) abiraterone or (ENZ) enzalutamide in poor prognosis metastatic castration-resistant prostate cancer (mCRPC)
Chi, K.N., Taavitsainen, S., Iqbal, N., Ferrario, C., Ong, M., Wadhwa, D., Hotte, S.J., Lo, G., Tran, B., Azad, A., Wood, L., Gingerich, J.R., North, S., Pezaro, C.V., Ruether, D., Sridhar, S.S., Annala, M., Bacon, J., Wyatt, A.W.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis
Gillessen, S., Schmid, S., Beltran, H., Almeida, D.V.P., Mehra, N., Lavaud, P., Morales Barrera, R., Pignataro, D., Castro Marcos, E., Conteduca, V., Efstathiou, E., Le, H.M.L., Pezaro, C.V., Suzuki, H., Zivi, A., Klingbiel, D., Omlin, A.G.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
2586 Pattern of presentation of brain metastases (BM) in metastatic renal cell cancer (mRCC) patients (pts) treated with targeted therapies (TT): Implications for screening practice
Spain, L, Dowling, A, Kwan, E, Pezaro, C, Dai, D, Chia, P, Tran, B, Pook, D, Weickhardt, A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from ‘castration-resistant’ prostate cancer
Pezaro, C.J., Omlin, A., Mastris, K., Attard, G., Beer, T.M., Chi, K.N., Chowdhury, S., Davis, I.D., Drake, C.G., de Bono, J.S., Efstathiou, E., Gravis, G., Higano, C.S., Hussain, M., James, N., Logothetis, C.J., Morgans, A., Parker, C., Ryan, C.J., Saad, F., Sartor, O., Small, E.J., Sternberg, C.N., Sweeney, C.J., Tannock, I., Tombal, B., Gillessen, S.
Published in Annals of oncology (01.08.2017)
Published in Annals of oncology (01.08.2017)
Get full text
Journal Article
2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC)
Lorente, D, Ravi, P, Mehra, N, Gillman, A, Omlin, A, Pezaro, C, Miranda, M, Mateo, J, Rescigno, P, Kolinsky, M, Porta, N, Jayaram, A, Bianchini, D, Hall, E, Ijzerman, M.J, De Bono, J.S
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article